目的：评价介入治疗晚期膀胱癌的疗效。
Objective To evaluate the effects of interventional therapy for advanced bladder cancer.
作者将就化疗对中晚期膀胱癌的生存影响进行综述。
This review will summarize the benefits chemotherapy for patients with advanced bladder cancer.
自1996年1月至今，我科为12例晚期膀胱癌患者施行了髂内动脉灌注化疗。
From Jan 1996 to Jun 1998, 12 patients with advanced or moderately advanced cancer of urinary bladder were treated by arterial infusion chemotherapy.
这类药物名叫检查点抑制剂，已经被食品与药物管理局批准，用于治疗晚期黑色素瘤、霍奇金淋巴瘤，以及肺癌、肾癌和膀胱癌。
These drugs, called checkpoint inhibitors, have been approved by the Food and drug Administration to treat advanced melanoma, Hodgkin lymphoma and cancers of the lung, kidney and bladder.
这类药物名叫检查点抑制剂，已经被食品与药物管理局批准，用于治疗晚期黑色素瘤、霍奇金淋巴瘤，以及肺癌、肾癌和膀胱癌。
These drugs, called checkpoint inhibitors, have been approved by the Food and drug Administration to treat advanced melanoma, Hodgkin lymphoma and cancers of the lung, kidney and bladder.
应用推荐